Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
Nanosonics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is accessible on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, including board responsibilities, director appointments, and accountability measures, reflecting its commitment to transparency and robust governance practices.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.15 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products, particularly in the field of ultrasound probe disinfection, aiming to enhance patient safety and reduce infection risks in medical settings.
YTD Price Performance: 34.55%
Average Trading Volume: 725,502
Technical Sentiment Signal: Buy
Current Market Cap: A$1.23B
Learn more about NAN stock on TipRanks’ Stock Analysis page.